Healthcare

Consistent with the firm’s overall focus, ROTH’s Healthcare banking team assists in the development of financing and growth strategies for public (or soon-to-be-public) small-cap companies. Our clients cover a broad spectrum of sectors including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies and devices. In some cases these companies require cash to complete the development of their product portfolio, while others need capital to fund the commercial launch of their programs. We also work closely with management and the Board of Directors in evaluating acquisition opportunities, licenses and strategic partnerships to accelerate growth and enhance shareholder value. We offer a full array of investment banking products and services including public and private offerings of equity and debt, advisory services and recapitalizations.

Our sub-sector focus includes:

Specialty pharmaceuticals
Medical technologies and devices
Biotechnology
Healthcare services and IT
China

Select Transactions:
(Click Here for additional Healthcare Transactions)

Contacts

Eric B. Cheng
Managing Director
Head of Healthcare
Investment Banking
646-358-1901
echeng@roth.com

Ted Roth
President
949-720-5753
troth@roth.com

Aaron M. Gurewitz
Managing Director
Head of Equity Capital Markets
949-720-5703
agurewitz@roth.com

Lou Ellis
Senior Vice President
Equity Capital Markets
949-720-5739
lellis@roth.com